National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.
New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.
A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England
An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).